Skip to content
Private Equity FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 10 SOURCES

Borromin Capital

Also known as Borromin Capital Management GmbH, Borromin, Steadfast Capital

Frankfurt partner-owned private equity firm (founded 2001, formerly Steadfast Capital) advising the Borromin Capital funds; MBOs, successions and growth deals in DACH and Benelux Mittelstand.

Frankfurt Mittelstand buyout manager, renamed from Steadfast Capital to Borromin in January 2020.

HEADQUARTERS
Frankfurt am Main, Germany
FOUNDED
2001
OUTSIDE CAPITAL
Yes
TEAM LISTED
13 people

Focus

STAGES
GrowthBuyout
ASSET MIX
Private equity
GEOGRAPHY
GermanyAustriaSwitzerlandNetherlandsBelgiumLuxembourg

Overview

Borromin was founded in Frankfurt in 2001 as an independent, partner-owned private equity advisory firm and currently advises the fifth Borromin fund, whose capital comes from domestic and foreign institutional and private investors. The funds provide equity for owner successions, management buy-outs, carve-outs and growth financing of Mittelstand companies, mainly in Germany but also in the DACH and Benelux region, with enterprise values of €20-150M. The firm, renamed from Steadfast Capital in 2020, is supervised by BaFin. Its most recent platform deal on the site is the August 2026 majority MBO of Dutch flat-roof specialist Hollanddak by Borromin Capital Fund V SCSp.

Investment thesis

Backs Mittelstand companies with a solid market position, clear growth potential and healthy profitability, where the experience and quality of the management team is of outstanding importance; 'at the end of the day we invest above all in people'.

PORTFOLIO (26)

  • Hollanddak
    Industrial & Manufacturing · since 2026
  • AXENTA
  • EBERLE
    since 2022
  • Aerotec
    Industrial & Manufacturing
  • von Wülfing
  • QITS
    Software & SaaS · since 2021
  • Cadence
  • Protect Medical
    HealthTech
  • WATR Group
    Exited
  • BUK Gruppe
  • Wilvo Gruppe
    Exited
  • Kempf Gruppe
    Industrial & Manufacturing
  • Guntermann & Drunck
    Industrial & Manufacturing · Exited
  • Stanzwerk Jessen
    Industrial & Manufacturing
  • Food & Service Gruppe
    Food & Agriculture
  • AVS Gruppe
    since 2013 · Exited
  • Barat Ceramics
  • proFagus
  • Falk & Ross Gruppe
  • MPS meat processing systems
    Food & Agriculture
  • Kautex Maschinenbau
    Industrial & Manufacturing
  • FEP Fahrzeugelektrik Pirna
    Industrial & Manufacturing
  • Cetelon Gruppe
  • Dahlback
  • Elaxy
    Software & SaaS
  • Little John Bikes
    Consumer & E-commerce

People

  • Nick Money-Kyrle
    Founding Partner; Managing Director · source
  • Marco Bernecker
    Managing Partner; Managing Director · source
  • Martin Franke
    Partner · source
  • Dr. Marc Schilling
    Partner · source
  • Jan Späth
    Partner · source
  • Viktor Strauch
    Partner · source
  • Daragh Queenan
    CFO · source
  • Maria Rostock
    General Counsel · source
  • Katharina Fege
    Investor Relations & Fundraising · source
  • Carl Pacher-Theinburg
    Investment Professional · source
  • Stephan Schömer
    Investment Professional · source
  • Andreas Ulrich
    Investment Professional · source
  • Justin Pearson
    Finance Manager · source

Links

Frequently asked questions

Borromin Capital is a private equity fund based in Frankfurt am Main, Germany, founded in 2001.

Yes. Borromin Capital invests its own capital in private companies.

Borromin Capital invests at Growth and Buyout stages in Industrial & Manufacturing, HealthTech, Consumer & E-commerce and Software & SaaS.

Key people at Borromin Capital include Nick Money-Kyrle (Founding Partner; Managing Director), Marco Bernecker (Managing Partner; Managing Director), Martin Franke (Partner) and Dr. Marc Schilling (Partner).

Borromin Capital's investments include Hollanddak, AXENTA, EBERLE, Aerotec, von Wülfing, QITS, Cadence and Protect Medical, among others.

The most recent publicly reported investment by Borromin Capital is TSG Associates (add-on to Protect Medical) (Add-on acquisition by portfolio company Protect Medical), announced in Oct 2026.

Yes. Borromin Capital manages capital from outside investors.